Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Scientists receive funds at 2020 event hosted by Center for BrainHealth

The Center for BrainHealth, part of The University of Texas at Dallas, recently hosted the first-ever virtual iteration of the annual Friends of BrainHealth Scientist Selection Luncheon, during which the following scientists were awarded funds for their independently designed research studies.

18 Nov 2020

Promising MS drug may make the debilitating disease worse

A drug that has shown promise for treating multiple sclerosis may actually make the debilitating disease worse, new research from the University of Virginia School of Medicine suggests.

15 Nov 2020

Inhaled nebulized interferon beta-1a (SNG001) helps COVID-19 patients recovers

Now, a team of researchers at the Synairgen Research, Southampton General Hospital, Southampton, United Kingdom, has found that inhaled nebulized interferon beta-1a (SNG001), a drug used for multiple sclerosis, helped COVID-19 patients have greater odds of improvement and recovery from SARS-CoV-2 infection.

15 Nov 2020

Study focuses on efficacy of cognitive rehabilitation across a range of neurological conditions

A new text by Kessler Foundation scientists focuses on the efficacy of cognitive rehabilitation across a variety of neurological conditions, with specific emphasis on treatment-related changes in the brain detectable via neuroimaging.

11 Nov 2020

Repairing brain damage caused by MS

Neurological symptoms as a result of Multiple Sclerosis (MS), such as loss of cognitive or motor function, lead to a great many problems for over 2.5 million people worldwide.

10 Nov 2020

How do low levels of oxygen damage the brain?

In this interview, Professor Paul Tesar and Kevin Allan speak to News-Medical about how low levels of oxygen damage the brain.

6 Nov 2020

Study investigates the ebb and flow of brain ventricles

Enlarged ventricles in the brains of people with multiple sclerosis were previously considered a sign of tissue loss.

5 Nov 2020

New study may help improve walking capacity in people with multiple sclerosis

Significant gaps in how walking capacity and performance is assessed for people with Multiple Sclerosis (MS) could be harming therapy and treatment development according to McGill University researchers.

3 Nov 2020

Beetroot peptide may be a good candidate for development of a drug to treat inflammatory diseases

In a recent study, a research group led by Christian Gruber at MedUni Vienna's Institute of Pharmacology isolated a peptide (small protein molecule) from beetroot.

30 Oct 2020

Study suggests a role for the hypothalamus in genetic susceptibility to IBD

Using sophisticated 3D genomic mapping and integrating with public data resulting from genome-wide association studies, researchers at Children's Hospital of Philadelphia have found significant genetic correlations between inflammatory bowel disease and stress and depression.

29 Oct 2020

Researchers develop guidelines to standardize performance tests for neural interfaces

How can scientists measure and define the performance of neural electrodes if there are no uniform standards? Freiburg microsystems engineer Dr. Maria Asplund together with Dr. Christian Böhler and Prof. Dr. Thomas Stieglitz, as well as Prof. Dr. Luciano Fadiga and Dr. Stefano Carli from the Italian Institute of Technology at the University of Ferrara, Italy, have developed guidelines to standardize the testing of the performance of electrodes for neural interfaces and bioelectronic systems.

29 Oct 2020

Study finds no association between leisure activities and lower dementia risk

Studies have suggested that taking part in leisure activities such as playing cards or gardening may be associated with a lower risk of developing dementia.

28 Oct 2020

Antiseizure drug use during pregnancy linked with double the risk of having children with autism

Women with epilepsy who take the antiseizure drug valproic acid while pregnant are at more than double the risk of having children with autism spectrum disorder and nearly double the risk of having children with attention deficit hyperactivity disorder (ADHD), according to a study in the October 28, 2020, online issue of Neurology, the medical journal of the American Academy of Neurology.

28 Oct 2020

Study: Four in 10 people with advanced multiple sclerosis are emotionally abused by caregivers

Four in 10 people with advanced multiple sclerosis, or MS, are emotionally abused by someone responsible for caring for them, reports a study led by the University of California, Riverside.

28 Oct 2020

Myeloid cells can suppress immune response, promote brain metastasis

Scientists have long believed that the brain protects itself from an aggressive immune response to keep down inflammation. However, that evolutionary control may work against it when a cancer cell attempts to spread to the brain, researchers at the University of Notre Dame have discovered.

27 Oct 2020

Researchers generate a transcriptomic map of the COVID brain

COVID-19 is known to be associated with multiple changes in gene expression, but many of these are also seen in chronic brain conditions as well as in some abnormal mental conditions. A recent study published on the preprint server bioRxiv in October 2020 uncovers the molecular basis of this association.

26 Oct 2020

Researchers validate new radiolabeled molecule used in imaging tests to detect brain injury

Researchers have validated a new radiolabeled molecule that can be used with imaging tests to accurately detect and characterize brain injury.

22 Oct 2020

Study shows how genetic predisposition contributes to the development of multiple sclerosis

About half of the people with multiple sclerosis have the HLA-DR15 gene variant. A study led by the University of Zurich has now shown how this genetic predisposition contributes to the development of the autoimmune disease multiple sclerosis in combination with environmental factors.

22 Oct 2020

Study reveals why oxygen deficiency impairs brain cells

Brain cell dysfunction in low oxygen is, surprisingly, caused by the very same responder system that is intended to be protective, according to a new published study by a team of researchers at the Case Western Reserve University School of Medicine.

22 Oct 2020

Mayo clinic researchers develop a potential test for Machado-Joseph disease

Mayo Clinic researchers, along with national and global collaborators, have developed a potential test for Machado-Joseph disease, or spinocerebellar ataxia type 3 (SCA3) ? a disease that has no cure.

22 Oct 2020